Fernanda Tavares-Da-Silva
5PUBLICATIONS
10CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (5)
Sort by Publication Date:
|Feb 01, 2024
A Model for Monitoring Spontaneously Reported Medication Errors Using the Adjuvanted Recombinant Zoster Vaccine as an Example.Christophe Dessart, Fernanda Tavares-Da-Silva, Lionel Van Holle
|Oct 08, 2021
An Analysis of Spontaneously Reported Data of Vesicular and Bullous Cutaneous Eruptions Occurring Following Vaccination with the Adjuvanted Recombinant Zoster Vaccine.Paola Pirrotta, Fernanda Tavares-Da-Silva, Maribel Co
|Jun 11, 2021
Safety Profile of the Adjuvanted Recombinant Zoster Vaccine in Immunocompromised Populations: An Overview of Six Trials.Marta López-Fauqued, Maribel Co-van der Mee, Adriana Bastidas
|Aug 31, 2020
Post-Marketing Safety Surveillance for the Adjuvanted Recombinant Zoster Vaccine: Methodology.Fernanda Tavares-Da-Silva, Olivia Mahaux, Lionel Van Holle
|Oct 05, 2019
The how's and what's of vaccine reactogenicity.Caroline Hervé, Béatrice Laupèze, Giuseppe Del Giudice
Pageof 1
Frequent Collaborators
3 joint publications
Jens-Ulrich Stegmann
2 joint publications
Caroline Hervé
2 joint publications
Olivia Mahaux
2 joint publications
Lionel Van Holle
1 joint publications
François Haguinet
1 joint publications
Harry Seifert
1 joint publications
Paola Pirrotta
1 joint publications
Maribel Co
1 joint publications
Nicolas Lecrenier
1 joint publications
Christophe Dessart
